ABSTRACT Congenital osteopetrosis in the mutant rat "op" is accompanied by early atrophy of the thymus gland. The response of thymocytes to concanavalin A and phytohemagglutinin P was greatly diminished at age 28 days, even before pronounced thymic atrophy could be detected.
ABSTRACT Congenital osteopetrosis in the mutant rat "op" is accompanied by early atrophy of the thymus gland. The response of thymocytes to concanavalin A and phytohemagglutinin P was greatly diminished at age 28 days, even before pronounced thymic atrophy could be detected. The response of spleen cells to mitogens that stimulate thymus-derived (T) and bone-marrow-derived (B) cells was diminished as early as 35 days of age. A single injection of a suspension of normal bone marrow, which cures osteopetrosis, increased thymus weight and restored the normal responses of both thymus and spleen to various mitogens. These results add further support to the hypothesis that the thymus is involved in the pathogenesis of osteopetrosis. Osteopetrosis is a disorder of the skeletal system of varying severity. Characteristic manifestations of the disease include poor differentiation of medullary cavities, bone fractures, severe anemia, and a marked delay in growth. The low incidence of this condition in humans (1/100,000 births) makes it difficult to study its pathogenesis and to assess the value of various treatments. In these respects, animal models of the disease are of great importance; they are available mostly in mice and in rats.
Osteopetrosis is inherited in an autosomal recessive manner and heals spontaneously in the "ia" (incisor absent) mutant rat (1) , whereas it is lethal in the "op" (osteopetrotic) mutant rat (2) . We have recently correlated the skeletal disorder of the op rat with rapid thymic atrophy seen as early as 4 weeks of age (3) . Either temporary parabiosis with a normal littermate (4, 5) or a single injection of normal bone marrow cells could cure the op mutant (4). When op female rats were treated with a single injection of bone marrow cells obtained from normal male siblings, cell migration could be studied by examination of cell karyotypes (3) . Donor cells (XY) were found in thymus and spleen of treated rats 2 weeks after intraperitoneal injection of male bone marrow. Six weeks later, recovery from osteopetrosis with bone resorption was observed. At this time, both XY and XX cells were seen in bone marrow as well as in thymus and spleen (3) . The skeletal recovery was preceded by a rapid and marked increase of thymus weight (3). Moreover, thymectomy performed prior to the injection of normal bone marrow prevented the cure of osteopetrosis in the op rat (6) . These results suggest two major disorders in the op rat: an impairment of bone marrow activity as a consequence of the progressive replacement of bone cavities by osseous tissue and a thymus atrophy.
The present study was designed to investigate the immuno- (4) .
Mitogens. Concanavalin A (Con A) (Miles) was used at 1, 3, or 10 Mg per culture (1 ml). Phytohemagglutinin P (PHA) (Difco) was used at a dose of 2 ,l per culture (1 ml). Lipopolysaccharide (LPS) was extracted from Salmonella enteritidis (Danysz strain) by the trichloroacetic acid procedure (7) . Nocardia water-soluble mitogen (NWSM) was prepared as previously described (8) . Peptidoglycan was obtained from Bacillus megaterium (9) . These three mitogens were tested at three doses: 1, 10, and 100,ug per culture (Table 1) Thus, the role of the thymus atrophy should be investigated in other mutant rats (1) and mice (15, 16 ). Previously we have suggested that the pathogenesis of osteopetrosis in the op rat involves the thymus (3, 6) . The present experiments add further support to the importance of the thymus in osteopetrosis. In addition they suggest a link between the immune system and the control of bone renewal. This idea may have clinical relevance and could lead to the management of osteopetrosis in man.
